the experiments, concentrations of CBZ and the bioTPs CBZ-Ep and CBZ-DH
were quantified by diluting the exposure medium with MeOH containing
an internal standard (IS) and then analyzing the diluted medium by
liquid chromatography tandem mass spectrometry (LC–MS/MS) using
an Ultimate 3000 ultrahigh-performance liquid chromatograph (UHPLC;
Thermo, USA) coupled to a TSQ Quantiva triple quadrupole mass spectrometer
(Thermo, USA) as described previously.21 (link) Further details are provided in the
4854, 445, 41, 3.85, and 0.46 μg/L, with RSDs ranging from 4–12%
(see
of the nominal. The increasing amount of dilution required to measure
CBZ in successively higher doses resulted in the intermittent quantification
of only CBZ-Ep (in the 43,367 and 445 μg/L doses) despite the
fact that CBZ-Ep and CBZ-DH were above detection limit in most doses
(following exposure).